Pfizer CEO Albert Burla Announces $43 Billion Acquisition of Seagen Cancer Biotechnology

Pfizer CEO Albert Burla Announces $43 Billion Acquisition of Seagen Cancer Biotechnology

“1 in 3 people in the world will get cancer in their lifetime… It's kind of like mRNA for vaccines, [but] it's for cancer treatment. Therefore, we think that with this technology in our hands, we can achieve very great results and bring relief to the whole world. On a scale never seen before due to this devastating disease, wow. And you also expect that it could generate about $10 billion in revenue for Pfizer by 20-30 years, contributing to the overall goal.”
The key word here is yield. They first increased the risk of cancer for everyone who underwent gene therapy, and now they want to save everyone again with another very profitable mRNA-like technology. Well, what a fabulous ....